How much does a box of Trastuzumab injection (subcutaneous injection) (Herceptin Hylecta) cost?

Trastuzumab injection (subcutaneous injection ) (Herceptin Hylecta) is a prescription medicine for adults with the following diseases: adjuvant (early-stage) HER2-positive breast cancer, metastatic breast cancer (breast cancer that has spread), Doctors will select patients for treatment based on the U.S. Food and Drug Administration (FDA) -approved companion diagnostic for trastuzumab.

Adjuvant (early stage)HER2-positive breast cancer is characterized by being node positive (has spread to lymph nodes) or node negative but with characteristics that put the patient at high risk for recurrence (ER/PR negative or have a high-risk profile), Trastuzumab injection (subcutaneous injection) may be used as part of a regimen consisting of doxorubicin, cyclophosphamide, and paclitaxel or docetaxel, or as part of a regimen of docetaxel and carboplatin, or as a single agent after multimodal anthracycline therapy. Trastuzumab injection (subcutaneous injection) in combination with paclitaxel can be used as a first-line treatment for HER2-overexpressing metastatic breast cancer and as a single agent for the treatment of HER2-overexpressing breast cancer in patients who have received one or more chemotherapy regimens for metastatic disease.

It is understood that the original drug of trastuzumab injection (subcutaneous injection) has been launched in China, but the specific price and other relevant information are not yet clear. Since the drug has been on the market for a short time, it has not been included in the scope of medical insurance. At present, there are no generic drugs of Trastuzumab injection (subcutaneous injection) produced and marketed. For more information and specific prices of Trastuzumab injection (subcutaneous injection), please consult a medical consultant.